Pragnell I B, Spandidos D A, Wilkie N M
Proc R Soc Lond B Biol Sci. 1985 Oct 22;226(1242):107-19. doi: 10.1098/rspb.1985.0085.
By using linkage to transcriptional enhancers to increase gene expression, it was shown that the introduction of the mutant Ha-ras gene from bladder carcinoma cells into primary cultures of Chinese and Syrian hamster cells, and Wistar rat cells, was sufficient to trigger malignant conversion. The normal Ha-ras gene when linked to enhancers did not trigger malignant conversion but gave rise to cell clones with extended growth capacity. We measured the levels of transforming growth factors (TGFs) released from cells containing the ras genes, and the availability of the receptor for epidermal growth factor (EGF) to which alpha-TGF also binds. The level of ras gene expression seemed to correlate with the level of TGF secreted, a reduction in available EGF receptors and the morphology of the transformed cells. However, when an immortalized cell line (rat 208F cells) was used as a recipient for the oncogene vectors a different result was obtained. TGF release was triggered to varying degrees by almost all of the ras and myc oncogene constructions tested, regardless of the level of gene expression. Enhanced expression of the two oncogenes led to increased anchorage-independence. Significantly, both normal ras and normal myc, when linked to transcriptional enhancers, caused the recipient cells to become tumorigeneic without inducing any marked morphological alterations in culture. Enhanced and constitutive expression of the mutant Ha-ras gene resulted in the recipient cells becoming tumorigeneic and the cells displayed a transformed phenotype in culture. The transfected fibroblasts with a markedly transformed phenotype displayed a relative paucity of EGF receptors which correlated with release of alpha-TGF, suggesting a down-regulation of EGF receptors on transformation. While enhanced expression of the normal Ha-ras gene did result in a decrease in EGF receptors on these transfectants, in contrast, the transfectants with enhanced expression of the c-myc and v-myc oncogenes did not display any significant changes in available EGF receptors although the cells were tumorigenic when tested in the nude mouse. These results are discussed in relation to a hypothesis implicating a role for oncogenes at various stages in the multi-stage process of carcinogenesis.
通过利用与转录增强子的连接来增加基因表达,研究表明,将膀胱癌细胞中的突变型Ha-ras基因导入中国仓鼠细胞、叙利亚仓鼠细胞和Wistar大鼠细胞的原代培养物中,足以引发恶性转化。正常的Ha-ras基因与增强子连接时不会引发恶性转化,但会产生具有延长生长能力的细胞克隆。我们测量了含有ras基因的细胞释放的转化生长因子(TGFs)水平,以及α-TGF也能结合的表皮生长因子(EGF)受体的可用性。ras基因表达水平似乎与分泌的TGF水平、可用EGF受体的减少以及转化细胞的形态相关。然而,当使用永生化细胞系(大鼠208F细胞)作为癌基因载体的受体时,得到了不同的结果。几乎所有测试的ras和myc癌基因构建体都不同程度地引发了TGF释放,而与基因表达水平无关。这两种癌基因的增强表达导致了锚定非依赖性增加。值得注意的是,正常的ras和正常的myc与转录增强子连接时,会使受体细胞具有致瘤性,而在培养中不会诱导任何明显的形态改变。突变型Ha-ras基因的增强和组成型表达导致受体细胞具有致瘤性,并且细胞在培养中表现出转化表型。具有明显转化表型的转染成纤维细胞显示出相对较少的EGF受体,这与α-TGF的释放相关,表明转化时EGF受体下调。虽然正常Ha-ras基因的增强表达确实导致这些转染体上的EGF受体减少,但相比之下,c-myc和v-myc癌基因增强表达的转染体在可用EGF受体方面没有显示出任何显著变化,尽管这些细胞在裸鼠中测试时具有致瘤性。本文结合一个涉及癌基因在多阶段致癌过程不同阶段作用的假说对这些结果进行了讨论。